All In Biotech

Free tool

FAERS Monitor: Diuril

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 011870 or its brand name (Diuril, Chlorothiazide). Reports on generic versions are filed under their own applications.

Reports

1,263

Serious

1,011

80% of reports

Hospitalization

635

Death reported

199

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use88
  • dyspnoea81
  • pyrexia79
  • diarrhoea73
  • hypotension71
  • drug ineffective66
  • pneumonia63
  • respiratory failure62
  • pain59
  • vomiting52
  • death50
  • cough48
  • headache48
  • renal failure45
  • condition aggravated42

Reports by year received

View as table
YearReports
200419
200525
200619
200725
200816
200927
201035
201155
201240
201353
201456
201555
201684
201763
2018120
2019107
2020108
202192
202293
202361
202443
202541
202626

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,896 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
respiratory failureSignal6214.211.1748
hypotensionSignal715.94.7286
renal failureSignal455.64.2168
pyrexiaSignal793.83.1163
pneumoniaSignal633.22.597
coughSignal482.92.257
dyspnoeaSignal812.41.965
condition aggravatedSignal422.31.730
diarrhoea731.91.530
vomiting521.81.420
off label use881.71.424
pain591.61.213
headache481.31.03
death501.00.70
drug ineffective660.80.72

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.